Strauss A, Gonzalez-Hernandez A, Lee J, Abreu N, Selvakumar P, Salas-Estrada L
Nat Commun. 2024; 15(1):6498.
PMID: 39090128
PMC: 11294631.
DOI: 10.1038/s41467-024-50548-x.
Nussinov R, Liu Y, Zhang W, Jang H
RSC Chem Biol. 2023; 4(11):850-864.
PMID: 37920394
PMC: 10619138.
DOI: 10.1039/d3cb00114h.
Nussinov R, Zhang M, Maloney R, Liu Y, Tsai C, Jang H
J Mol Biol. 2022; 434(17):167569.
PMID: 35378118
PMC: 9398924.
DOI: 10.1016/j.jmb.2022.167569.
Orgovan Z, Ferenczy G, Keseru G
ChemMedChem. 2020; 16(1):81-93.
PMID: 32686363
PMC: 7818470.
DOI: 10.1002/cmdc.202000444.
Prasannan C, Gmyrek A, Martin T, Villar M, Artigues A, Lee J
Biophys J. 2020; 118(12):2966-2978.
PMID: 32479745
PMC: 7300342.
DOI: 10.1016/j.bpj.2020.05.012.
Evaluation of Synthetic Cytochrome P-Mimetic Metalloporphyrins To Facilitate "Biomimetic" Biotransformation of a Series of mGlu Allosteric Ligands.
Presley C, Perry C, Childress E, Mulder M, Luscombe V, Rodriguez A
ACS Omega. 2019; 4(7):12782-12789.
PMID: 31460402
PMC: 6690571.
DOI: 10.1021/acsomega.9b02017.
Drug Design Strategies for GPCR Allosteric Modulators.
Conn P, Kuduk S, Doller D
Annu Rep Med Chem. 2016; 47:441-457.
PMID: 26962268
PMC: 4780677.
DOI: 10.1016/B978-0-12-396492-2.00028-X.
Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.
Gregory K, Conn P
Mol Pharmacol. 2015; 88(1):188-202.
PMID: 25808929
PMC: 4468636.
DOI: 10.1124/mol.114.097220.
2013 Philip S. Portoghese Medicinal Chemistry Lectureship: drug discovery targeting allosteric sites.
Lindsley C
J Med Chem. 2014; 57(18):7485-98.
PMID: 25180768
PMC: 4174999.
DOI: 10.1021/jm5011786.
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.
Conn P, Lindsley C, Meiler J, Niswender C
Nat Rev Drug Discov. 2014; 13(9):692-708.
PMID: 25176435
PMC: 4208620.
DOI: 10.1038/nrd4308.
Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs.
Wenthur C, Morrison R, Daniels J, Conn P, Lindsley C
Bioorg Med Chem Lett. 2014; 24(12):2693-8.
PMID: 24794112
PMC: 4075068.
DOI: 10.1016/j.bmcl.2014.04.051.
Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.
Yin S, Niswender C
Cell Signal. 2014; 26(10):2284-97.
PMID: 24793301
PMC: 4130774.
DOI: 10.1016/j.cellsig.2014.04.022.
Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.
Dhanya R, Sheffler D, Dahl R, Davis M, Lee P, Yang L
J Med Chem. 2014; 57(10):4154-72.
PMID: 24735492
PMC: 4033659.
DOI: 10.1021/jm5000563.
Drugs for allosteric sites on receptors.
Wenthur C, Gentry P, Mathews T, Lindsley C
Annu Rev Pharmacol Toxicol. 2013; 54:165-84.
PMID: 24111540
PMC: 4063350.
DOI: 10.1146/annurev-pharmtox-010611-134525.
Emerging paradigms in GPCR allostery: implications for drug discovery.
Wootten D, Christopoulos A, Sexton P
Nat Rev Drug Discov. 2013; 12(8):630-44.
PMID: 23903222
DOI: 10.1038/nrd4052.
Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.
Melancon B, Hopkins C, Wood M, Emmitte K, Niswender C, Christopoulos A
J Med Chem. 2011; 55(4):1445-64.
PMID: 22148748
PMC: 3349997.
DOI: 10.1021/jm201139r.
Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected 'molecular switch' from a closely related mGlu4 positive allosteric modulator.
Utley T, Haddenham D, Salovich J, Zamorano R, Vinson P, Lindsley C
Bioorg Med Chem Lett. 2011; 21(23):6955-9.
PMID: 22030026
PMC: 3319082.
DOI: 10.1016/j.bmcl.2011.09.131.
Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.
Noetzel M, Rook J, Vinson P, Cho H, Days E, Zhou Y
Mol Pharmacol. 2011; 81(2):120-33.
PMID: 22021324
PMC: 3263948.
DOI: 10.1124/mol.111.075184.
"Molecular switches" on mGluR allosteric ligands that modulate modes of pharmacology.
Wood M, Hopkins C, Brogan J, Conn P, Lindsley C
Biochemistry. 2011; 50(13):2403-10.
PMID: 21341760
PMC: 3792571.
DOI: 10.1021/bi200129s.